Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.
- NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_assertion description "[Subjects who were heterozygous or homozygous for the cytochrome P450 gene variant CYP1B1 V432L G allele were at slightly greater risk of non-Hodgkin's lymphoma [odds ratio (OR), 1.27; 95% confidence interval (95% CI), 0.97-1.65]; these results were consistent across B-cell lymphoma subtypes and among both non-Hispanic White and Black subjects, although not statistically significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.
- NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_assertion evidence source_evidence_literature NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.
- NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_assertion SIO_000772 16985026 NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.
- NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_assertion wasDerivedFrom befree-20150227 NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.
- NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_assertion wasGeneratedBy ECO_0000203 NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP341021.RAHWWGVPySWsiDaga9q-vLYUiFUKjjeg3zIdj66Qb3mq4130_provenance.